For in” rel=”nofollow”>instructions please go to uploaded file named Article types.docx follow all of the requirements to arrange the paper under the correct headin” rel=”nofollow”>ings there is no need for you to write the paper its just you need to put it in” rel=”nofollow”>in the correct format. Then for in” rel=”nofollow”>instructions please go to uploaded file named Equity focused HIA v5.doc this is the actual paper that you need to work on. Basically all I need from you is break the paper under the correct headin” rel=”nofollow”>ings and format

Article types

Origin” rel=”nofollow”>inal articles: The form of these articles is discussed fully below; an abstract is required. They should be no longer than 4000 words and 40 references (as above, please note that word count also excludes tables, figures and legends).

Authorship

All authors should have made substantial contributions to all of the followin” rel=”nofollow”>ing: (1) the conception and design of the study, or acquisition of data, or analysis and in” rel=”nofollow”>interpretation of data, (2) draftin” rel=”nofollow”>ing the article or revisin” rel=”nofollow”>ing it critically for important in” rel=”nofollow”>intellectual content, (3) fin” rel=”nofollow”>inal approval of the version to be submitted.

Manuscript Submission

Permissions

Authors wishin” rel=”nofollow”>ing to in” rel=”nofollow”>include figures, tables, or text passages that have already been published elsewhere are required to obtain” rel=”nofollow”>in permission from the copyright owner(s) for both the prin” rel=”nofollow”>int and onlin” rel=”nofollow”>ine format and to in” rel=”nofollow”>include evidence that such permission has been granted when submittin” rel=”nofollow”>ing their papers. Any material received without such evidence will be assumed to origin” rel=”nofollow”>inate from the authors.

Submission Checklist

Please ensure that the followin” rel=”nofollow”>ing are in” rel=”nofollow”>includin” rel=”nofollow”>ing in” rel=”nofollow”>in your submission:

1. One author designated as correspondin” rel=”nofollow”>ing author: Their E-mail address, Full postal address, Telephone numbers

4. Keywords

5. All figure captions

6. All tables (in” rel=”nofollow”>includin” rel=”nofollow”>ing title, description, footnotes)

7. All necessary files have been uploaded as attachments to the e-mail

8. Manuscript has been spell checked

9. All text pages have been numbered

10. References are in” rel=”nofollow”>in the correct format for this journal

11. All references mentioned in” rel=”nofollow”>in the Reference list are cited in” rel=”nofollow”>in the text and vice versa

12. Permission has been obtain” rel=”nofollow”>ined for use of copyrighted material from other sources (in” rel=”nofollow”>includin” rel=”nofollow”>ing the Web)
Manuscript preparation

Please type all pages with sin” rel=”nofollow”>ingle spacin” rel=”nofollow”>ing and wide margin” rel=”nofollow”>ins on one side of the paper. Title page, abstract, tables, legends to figures and reference list should each be provided on separate pages of the manuscript.

Use a normal, plain” rel=”nofollow”>in font (e.g., 12-poin” rel=”nofollow”>int Times New Roman) for text. The text should be in” rel=”nofollow”>in sin” rel=”nofollow”>ingle-column format. Number the pages. Keep the layout of the text as simple as possible. In particular, do not use the options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. Do not embed ‘graphically designed’ equations or tables, but prepare these usin” rel=”nofollow”>ing the facility in” rel=”nofollow”>in Word or as a separate file in” rel=”nofollow”>in Excel. When preparin” rel=”nofollow”>ing tables, if you are usin” rel=”nofollow”>ing a table grid, use only one grid for each in” rel=”nofollow”>individual table and not a grid for each row. Do not prepare tables in” rel=”nofollow”>in Powerpoin” rel=”nofollow”>int. Do not import the figures in” rel=”nofollow”>into the text file but, in” rel=”nofollow”>instead, in” rel=”nofollow”>indicate their approximate locations directly on the manuscript.

To avoid unnecessary errors you are strongly advised to use the spellchecker.

The title page should in” rel=”nofollow”>include: the title, the name(s) and affiliation(s) of the author(s), an address for correspondence, and telephone numbers for editorial queries. Origin” rel=”nofollow”>inal and review articles should in” rel=”nofollow”>include an Abstract (a sin” rel=”nofollow”>ingle paragraph) of no more than 250 words and 3-6 key words for abstractin” rel=”nofollow”>ing and in” rel=”nofollow”>indexin” rel=”nofollow”>ing purposes.

Please do not split the article in” rel=”nofollow”>into separate files (title page as one file, text as another, etc.). Do not allow your computer to in” rel=”nofollow”>introduce word splits and do not use a ‘justified’ layout. Please adhere strictly to the general in” rel=”nofollow”>instructions on style/arrangement and, in” rel=”nofollow”>in particular, the reference style of the journal. It is very important that you save your file in” rel=”nofollow”>in the standard format for the program you are usin” rel=”nofollow”>ing (Microsoft Word docx format or doc format). Please write your text in” rel=”nofollow”>in good English (American or British usage is accepted, but not a mixture of these).

Provide the followin” rel=”nofollow”>ing in” rel=”nofollow”>information in” rel=”nofollow”>in your submission (in” rel=”nofollow”>in the order given):

Origin” rel=”nofollow”>inal research papers

1. Manuscripts must be accompanied by a coverin” rel=”nofollow”>ing letter, in” rel=”nofollow”>introducin” rel=”nofollow”>ing the manuscript and confirmin” rel=”nofollow”>ing that it is not bein” rel=”nofollow”>ing submitted concurrently elsewhere.

2. The Abstract should be no more than 250 words

3. The limit for the main” rel=”nofollow”>in body of the manuscript is 4000 words excludin” rel=”nofollow”>ing references

4. There should not normally be more than 40 references

5. You must use Times New Roman, Font size 12, Sin” rel=”nofollow”>ingle spaced throughout your manuscript

If your manuscript exceeds the above limits, and you are unable to reduce the size, please in” rel=”nofollow”>include a statement in” rel=”nofollow”>in your cover letter declarin” rel=”nofollow”>ing that you have exceeded the limits and justify the reasons for doin” rel=”nofollow”>ing so for the Editors’ consideration. Manuscripts must in” rel=”nofollow”>include:

1. Title page

2. Abstract

3.Introduction

4.Methods

5.Results

6.Discussion and conclusions

7.Acknowledgements

8.Declarations

9.References

10.Tables

11.Figures and Legends

1. Title page

The title page should be pagin” rel=”nofollow”>inated as page 1 of the manuscript. Title of article: Concise and in” rel=”nofollow”>informative. Titles are often used in” rel=”nofollow”>in in” rel=”nofollow”>information-retrieval systems. Avoid abbreviations and formulae where possible.

Author names and affiliations: The title page should in” rel=”nofollow”>include the names and addresses of authors. Generally for uniformity author names should be written as first name, middle name in” rel=”nofollow”>initial followed by family name, e.g. James Z. Miller. Present the authors’ affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author’s name and in” rel=”nofollow”>in front of the appropriate address. Provide the full postal address of each affiliation, in” rel=”nofollow”>includin” rel=”nofollow”>ing the country name.

2. Abstract

The abstract will be prin” rel=”nofollow”>inted at the begin” rel=”nofollow”>innin” rel=”nofollow”>ing of the paper. A concise and factual abstract is required (maximum length 250 words). The abstract should state briefly the purpose of the research, the prin” rel=”nofollow”>incipal results and major conclusions. Do not cite references in” rel=”nofollow”>in the abstract. Non-standard or uncommon abbreviations should be avoided in” rel=”nofollow”>in the abstract, but if essential they must be defin” rel=”nofollow”>ined at their first mention in” rel=”nofollow”>in the abstract itself. The abstract must be organized under the followin” rel=”nofollow”>ing subject headin” rel=”nofollow”>ings: Background: This must in” rel=”nofollow”>indicate why the study was performed, and what question it was in” rel=”nofollow”>intended to answer. Methods: This should state in” rel=”nofollow”>in outlin” rel=”nofollow”>ine what methods were used. Results: The main” rel=”nofollow”>in results relevant to the question addressed should be summarised. Conclusions: This should summarize the main” rel=”nofollow”>in in” rel=”nofollow”>inferences that follow from the results. Keywords. Immediately after the abstract, provide a maximum of 6 keywords. Be sparin” rel=”nofollow”>ing with abbreviations: only abbreviations firmly established in” rel=”nofollow”>in the field may be eligible. Defin” rel=”nofollow”>ine abbreviations that are not standard in” rel=”nofollow”>in this field at their first occurrence in” rel=”nofollow”>in the article: in” rel=”nofollow”>in the abstract but also in” rel=”nofollow”>in the main” rel=”nofollow”>in text after it.

3. Introduction

The in” rel=”nofollow”>introduction should give a short and clear account of the background of the problem and state the objectives of the work. Only previous work that has a direct bearin” rel=”nofollow”>ing on the present problem should be cited.

4. Methods

The methods must be described in” rel=”nofollow”>in sufficient detail to allow the experiments to be in” rel=”nofollow”>interpreted and repeated by an experienced in” rel=”nofollow”>investigator. Where published methods are used, references should be given, together with a brief outlin” rel=”nofollow”>ine. The statistical tool used to analyze the data should be mentioned. The description of drugs, chemicals and other materials should in” rel=”nofollow”>include the names and brief address of the relevant suppliers. Drug names should be International Non-proprietary Names (INN). If a drug has no INN its full chemical name must be used. All procedures in” rel=”nofollow”>involvin” rel=”nofollow”>ing experimental animals or human subjects must accompany a statement on ethical approval from appropriate ethics committee.

Reports of randomized, controlled trials should follow the recommendations of the Consolidated Standards of Reportin” rel=”nofollow”>ing Trials (CONSORT) statement.

Reportin” rel=”nofollow”>ing guidelin” rel=”nofollow”>ines for specific study designs:
Initiative Type of Study Source
CONSORT Randomized controlled trials http://www.consort-statement.org

STARD Studies of diagnostic accuracy http://www.consort-statement.org/stardstatement.htm

QUOROM Systematic reviews and meta-analyses http://www.consort-statement.org/Initiatives/MOOSE/moose.pdf

STROBE Observational studies in” rel=”nofollow”>in epidemiology http://www.strobe-statement.org

MOOSE Meta-analyses of observational studies in” rel=”nofollow”>in epidemiology http://www.consort-statement.org/Initiatives/MOOSE/moose.pdf

5. Results

Present your results in” rel=”nofollow”>in a logical sequence in” rel=”nofollow”>in the text, tables, and figures, givin” rel=”nofollow”>ing the main” rel=”nofollow”>in or most important fin” rel=”nofollow”>indin” rel=”nofollow”>ings first. Do not repeat in” rel=”nofollow”>in the text all the data in” rel=”nofollow”>in the tables or figures; emphasize or summarize only important observations.

6. Discussion and Conclusions

The purpose of the discussion is to present a brief and pertin” rel=”nofollow”>inent in” rel=”nofollow”>interpretation of the results again” rel=”nofollow”>inst the background of existin” rel=”nofollow”>ing knowledge. Any assumptions on which conclusions are based must be stated clearly. The main” rel=”nofollow”>in conclusions should be conveyed in” rel=”nofollow”>in a fin” rel=”nofollow”>inal paragraph with a clear statement of how the study advances knowledge and understandin” rel=”nofollow”>ing in” rel=”nofollow”>in the field.

7. Acknowledgements

Collate acknowledgements in” rel=”nofollow”>in a separate section at the end of the article and do not, therefore, in” rel=”nofollow”>include them on the title page, as a footnote to the title or otherwise. When the work in” rel=”nofollow”>included in” rel=”nofollow”>in a paper has been supported by a grant from any source, this must be in” rel=”nofollow”>indicated. A connection of any author with companies producin” rel=”nofollow”>ing any substances or apparatus used in” rel=”nofollow”>in the work should be declared. All contributors who do not meet the criteria for authorship as defin” rel=”nofollow”>ined above should be listed in” rel=”nofollow”>in an acknowledgements section. Examples of those who might be acknowledged in” rel=”nofollow”>include a person who provided purely technical help, writin” rel=”nofollow”>ing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writin” rel=”nofollow”>ing assistance and identify the entity that paid for this assistance.

8. Declarations

This in” rel=”nofollow”>information must also be in” rel=”nofollow”>inserted in” rel=”nofollow”>into your manuscript under the acknowledgements section with the headin” rel=”nofollow”>ings below. If you have no declaration to make please in” rel=”nofollow”>insert the followin” rel=”nofollow”>ing statements in” rel=”nofollow”>into your manuscript:

Fundin” rel=”nofollow”>ing: None
Conflict of in” rel=”nofollow”>interest: None declared
Ethical approval: Not required

9. References

References should be numbered consecutively as they appear in” rel=”nofollow”>in the text. Reference citations in” rel=”nofollow”>in the text should be identified by numbers in” rel=”nofollow”>in superscript after the punctuation marks. All authors should be quoted for papers with up to six authors; for papers with more than six authors, the first six should be quoted followed by et al.

Journal article:

Garber A, Klein” rel=”nofollow”>in E, Bruce S, Sankoh S, Mohideen P. Metformin” rel=”nofollow”>in-glibenclamide versus metformin” rel=”nofollow”>in plus rosiglitazone in” rel=”nofollow”>in patients with type 2 diabetes in” rel=”nofollow”>inadequately controlled on metformin” rel=”nofollow”>in monotherapy. Diabetes Obes Metab 2006;8:156-63

Book chapter:

O’Brien C. Drug addiction and drug abuse. In: Brunton LB, Lazo JS, Parker KL, eds.Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2005: 607-629.

Website:

National Cancer Institute. Fact sheet: targeted cancer therapies, 2012. Available at http://www.cancer.gov/cancertopics/factsheet/Therapy/targeted#q1.Accessed 9 June 2012.

10. Tables

Each table should be given on a separate page, pagin” rel=”nofollow”>inated as part of the paper. Tables should be numbered consecutively with Arabic numerals and the number should be followed by a brief descriptive caption, occupyin” rel=”nofollow”>ing not more than two lin” rel=”nofollow”>ines, at the head of the table (e.g. Table 1: Effect of drug on blood pressure). Tables should normally be self-explanatory, with necessary descriptions provided underneath the table. Each column should have a headin” rel=”nofollow”>ing and the units of measurement should be given in” rel=”nofollow”>in parentheses in” rel=”nofollow”>in the headin” rel=”nofollow”>ing. Footnotes to tables should be in” rel=”nofollow”>indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and in” rel=”nofollow”>included beneath the table body.

11. Figures and Legends

Authors are encouraged to use color to enhance the impact and clarity of figures. There is no charge for usin” rel=”nofollow”>ing color in” rel=”nofollow”>in International Journal of Community Medicin” rel=”nofollow”>ine and Public Health. For figures supplied in” rel=”nofollow”>in parts, please use A, B, C, etc. to label the panels or parts of the figure. Name your figure files with Figure and the figure number, e.g., Figure 1: Liver enzyme levels. For the best quality fin” rel=”nofollow”>inal product, it is highly recommended that you submit all of your artwork photographs, lin” rel=”nofollow”>ine drawin” rel=”nofollow”>ings, etc. – in” rel=”nofollow”>in an electronic format. Computer prepared images must be at a min” rel=”nofollow”>inimum of 300 dpi at the fin” rel=”nofollow”>inal publication size. Lower resolution will result in” rel=”nofollow”>in pixilation and poor quality images. These should be submitted as JPEG or TIFF.

Figure legends should be typed on a separate page of the main” rel=”nofollow”>in manuscript document. Legends should explain” rel=”nofollow”>in the figures in” rel=”nofollow”>in sufficient detail that, whenever possible, they can be understood without reference to the text. Legends, captions and labels should be consistent with termin” rel=”nofollow”>inology or nomenclature used in” rel=”nofollow”>in the text.

the authors. The correspondin” rel=”nofollow”>ing author and all co-authors, signs a copyright transfer form at the time of submission of the manuscript. Copyright form can be downloaded from here

You have to upload three files (i.e. Manuscript file, Cover letter and Copyright form) for onlin” rel=”nofollow”>ine manuscript submission.
Download sample files
Manuscript file (Main” rel=”nofollow”>in Article file in” rel=”nofollow”>in doc or docx file, Sample file for Research Article here)
Cover letter (in” rel=”nofollow”>in doc or docx file)
Copyright form (in” rel=”nofollow”>in doc, docx, pdf or jpg file)